Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans
- PMID: 25829001
- DOI: 10.1093/cid/civ261
Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans
Abstract
Background: Influenza is a significant cause of morbidity and mortality in older adults. High-dose (HD) trivalent inactivated vaccine has increased immunogenicity in older adults compared with standard-dose (SD) vaccine. We assessed the relative effectiveness of HD influenza vaccination (vs SD influenza vaccination).
Methods: We conducted a retrospective cohort study among patients who receive primary care at Veteran Health Administration (VHA) medical centers, and who received influenza vaccine in the 2010-2011 influenza season. The primary outcome was hospitalization for influenza or pneumonia. We also conducted an analysis in subgroups defined by age.
Results: We evaluated 25 714 patients who received HD vaccine and 139 511 who received SD vaccine in 23 VHA medical centers. The rate of hospitalization for influenza or pneumonia was 0.3% in both groups in the influenza season. After accounting for patient characteristics in propensity-adjusted analyses, the risk of hospitalization for influenza or pneumonia was not significantly lower among patients receiving HD vaccine vs those receiving SD vaccine (risk ratio, 0.98; 95% confidence interval, .68-1.40). In the subgroup of patients ā„85 years of age, receiving HD (compared with SD) vaccine was associated with lower rates of hospitalization for influenza or pneumonia.
Conclusions: HD vaccine was not found to be more effective than SD vaccine in protecting against hospitalization for influenza or pneumonia; however, we found a protective effect in the oldest subgroup of patients. Additional studies are needed to evaluate the effectiveness of HD vaccine.
Keywords: comparative effectiveness research; elderly; influenza human; influenza vaccines.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Comment in
-
Regarding Primary Care Patients Who Received Influenza Vaccine at Veteran Health Administration Medical Centers.Clin Infect Dis. 2015 Oct 15;61(8):1344-5. doi: 10.1093/cid/civ547. Epub 2015 Jul 8. Clin Infect Dis. 2015. PMID: 26157048 No abstract available.
-
Reply to Decker et al.Clin Infect Dis. 2015 Oct 15;61(8):1345. doi: 10.1093/cid/civ549. Epub 2015 Jul 8. Clin Infect Dis. 2015. PMID: 26157051 No abstract available.
Similar articles
-
Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.Vaccine. 2019 Mar 7;37(11):1484-1490. doi: 10.1016/j.vaccine.2019.01.063. Epub 2019 Feb 8. Vaccine. 2019. PMID: 30745146
-
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines.Vaccine. 2015 Sep 11;33(38):4988-93. doi: 10.1016/j.vaccine.2015.07.006. Epub 2015 Jul 26. Vaccine. 2015. PMID: 26212007 Clinical Trial.
-
High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15.Euro Surveill. 2020 May;25(19):1900401. doi: 10.2807/1560-7917.ES.2020.25.19.1900401. Euro Surveill. 2020. PMID: 32431290 Free PMC article.
-
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis.Expert Rev Vaccines. 2018 May;17(5):435-443. doi: 10.1080/14760584.2018.1471989. Epub 2018 May 16. Expert Rev Vaccines. 2018. PMID: 29715054 Review.
-
Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.Vaccine. 2021 Mar 15;39 Suppl 1:A24-A35. doi: 10.1016/j.vaccine.2020.09.004. Epub 2021 Jan 7. Vaccine. 2021. PMID: 33422382 Review.
Cited by 15 articles
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.MMWR Recomm Rep. 2021 Aug 27;70(5):1-28. doi: 10.15585/mmwr.rr7005a1. MMWR Recomm Rep. 2021. PMID: 34448800 Free PMC article.
-
Relative effectiveness of influenza vaccines in elderly persons in the United States, 2012/2013-2017/2018 seasons.NPJ Vaccines. 2021 Aug 24;6(1):108. doi: 10.1038/s41541-021-00373-w. NPJ Vaccines. 2021. PMID: 34429431 Free PMC article.
-
Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians.J Gen Intern Med. 2021 Jul;36(7):2030-2038. doi: 10.1007/s11606-020-06397-7. Epub 2021 Jan 22. J Gen Intern Med. 2021. PMID: 33483822
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.MMWR Recomm Rep. 2020 Aug 21;69(8):1-24. doi: 10.15585/mmwr.rr6908a1. MMWR Recomm Rep. 2020. PMID: 32820746 Free PMC article.
-
Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.Vaccine. 2020 Sep 29;38(42):6562-6569. doi: 10.1016/j.vaccine.2020.08.011. Epub 2020 Aug 13. Vaccine. 2020. PMID: 32800465 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Medical
